| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0360-3016(01)01468-7 |
| P698 | PubMed publication ID | 11380223 |
| P2093 | author name string | A W Chan | |
| C C Wang | |||
| W Montgomery | |||
| M Ancukiewicz | |||
| N Carballo | |||
| P2860 | cites work | PROGNOSTIC SIGNIFICANCE OF EXTENT OF TUMOR REGRESSION AT COMPLETION OF RADIATION THERAPY | Q78375256 |
| Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer | Q36800735 | ||
| Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high dose per fraction radiotherapy. Analysis of neck disease response in 1646 cases | Q39739969 | ||
| Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolarynx cancers managed by definitive radiotherapy | Q44632918 | ||
| Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck: is postradiotherapy neck dissection necessary? | Q45110187 | ||
| Long-term regional control after radiation therapy and neck dissection for base of tongue carcinoma | Q50180551 | ||
| A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. | Q50561584 | ||
| Prognostic factors of local control after radiotherapy in T1 glottic and supraglottic carcinoma of the larynx. | Q51013020 | ||
| Results of accelerated radiotherapy for supraglottic carcinoma: a Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary experience. | Q53925481 | ||
| Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases | Q57770602 | ||
| Regression rate of metastatic neck lymph nodes after radiation treatment as a prognostic factor for local control | Q69040403 | ||
| Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival | Q69491043 | ||
| Neck dissection after twice-a-day radiotherapy: morbidity and recurrence rates | Q69784915 | ||
| Twice-a-day radiation therapy for supraglottic carcinoma | Q69996204 | ||
| Radiotherapy of lymph node metastases in patients with squamous cell carcinoma of the head and neck region | Q70429245 | ||
| Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy | Q71747308 | ||
| Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) | Q72149116 | ||
| Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes | Q72993368 | ||
| Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all? | Q72993381 | ||
| Is radiation therapy a preferred alternative to surgery for squamous cell carcinoma of the base of tongue? | Q73330158 | ||
| Radiation therapy for squamous cell carcinoma of the tonsillar region: a preferred alternative to surgery? | Q73829264 | ||
| Planned postradiotherapy neck dissection in patients with advanced head and neck cancer | Q74250918 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 367-375 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | The role of postradiotherapy neck dissection in supraglottic carcinoma | |
| P478 | volume | 50 |
| Q60637546 | Cancer of the larynx |
| Q45146567 | Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: salvage in the dissected or undissected neck |
| Q80474215 | Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection? |
| Q38210213 | Management of advanced laryngeal cancer |
| Q36916704 | Management of the Neck after Treatment with Radiation with or without Chemotherapy |
| Q37625438 | Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009. |
| Q80735772 | N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02 |
| Q34153043 | Neck control after definitive radiochemotherapy without planned neck dissection in node-positive head and neck cancers |
| Q79262163 | Neck level–specific nodal metastases in oropharyngeal cancer: Is there a role for selective neck dissection after definitive radiation therapy? |
| Q34985889 | Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck |
| Q37538615 | Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence |
| Q50990769 | Predictors of radiotherapy outcome in patients with T2 supraglottic carcinoma. |
| Q80168624 | Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma |
Search more.